If using genetic resources covered by the Nagoya Protocol, there are two checkpoints in the research and development phase where a due diligence declaration must be submitted to the UK Competent Authority (ABS Process; step 5).
|
Checkpoint |
Timescale for Declaration | To whom? |
|---|---|---|
| 1. When in receipt of research grants to support the utilization of the genetic resource | After the receipt of the first instalment of funding but before the final project report or project end; | Defra (via Research Office). |
| 2. Reaching the final stages of product development (i.e. commercialisation) as a result of utilising the genetic resource | At the stage of final development of a product, developed from the utilisation of genetic resources and / or aTK. |
Defra (via Research Office). |
On reaching either checkpoint:
- Complete the relevant due diligence declaration template:
due_diligence_form_receipt_of_research_funding.docx (305.4 KB)- due_diligence_form_commercialisation.docx (306.72 KB)
- Send the completed form to the research governance team who will assist in submitting the declaration to the Defra on behalf of the University